Novamed-Medley effects on Brazil government drug contracts probed by CADE
Brazil's antitrust authority is investigating whether Novamed's proposed acquisition of Medley Farmacêutica could affect competition in the public procurement of medicine. The agency is seeking the Health Ministry's views on the...To view the full article, register now.
Already a subscriber? Click here to view full article